G-BA decisions from 17 Apr 2025
Here are the latest G-BA decisions from the G-BA meeting held on 17 April 2025 on the early benefit assessments of Vaborem,
German Market Access – Simplified
Everything you need to know in one place, explained in simple terms
Here are the latest G-BA decisions from the G-BA meeting held on 17 April 2025 on the early benefit assessments of Vaborem,
Here are the latest G-BA decisions from the G-BA meeting held on 3 April 2025 on the early benefit assessments of Keytruda,
Here are the latest G-BA decisions from the G-BA meeting held on 20 March 2025 on the early benefit assessments of Tecentriq,
Here are the latest G-BA decisions from the G-BA meeting held on 6 March 2025 on the early benefit assessments of Winrevair,
Here are the latest G-BA decisions from the G-BA meeting held on 20 February 2025 on the early benefit assessments of Emblaveo,